COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1870 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-10

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

CON-VINCE (COvid-19 National survey for assessing VIral spread by Non-affected CarriErs) is a national, monocentric, and longitudinal study aiming to evaluate the spread dynamics of the COVID-19 disease within the Luxembourgish population. Participants who are clinically asymptomatic or present with only mild symptoms will be followed up longitudinally, regularly tested for SARS-CoV-2 by RT-PCR, antibody status, and subjected to an epidemiological, clinical and biological phenotyping to better understand the nature, dynamics of infectivity and spread of the virus in the population. CON-VINCE will also track the psychological and socio-economic impact of long-term containment measures on the general population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Convalescent Plasma for COVID-19 Research Donor Study

NCT04555109

Covid19

UNKNOWN

Acquiring Convalescent Specimens for COVID-19 Antibodies

NCT04342195

COVID-19 Coronavirus Infection Corona Virus Infection

COMPLETED

COVID-19 Recovered Volunteer Research Participant Pool Registry

NCT04359602

Recovered From COVID-19

ACTIVE_NOT_RECRUITING

Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.

NCT04954937

Healthy

UNKNOWN

Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients

NCT07134673

Long COVID Post-COVID-19 Condition

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To capture the dynamics and impact of the virus spread in the Luxembourgish population, data and sample collection is done every two weeks for two months (4 times in total) with a final follow-up one year after the participant's inclusion in the study. Participants complete questionnaires before each sample collection. The baseline questionnaire captures demographic data, medical history, behavioral and psychological data, and socio-economic status. Participants provided information on medical history, history of allergies, smoking, and chronic medication taken regularly. COVID-19-related data and environmental conditions of the household were obtained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 18 and older of both genders, with a full capacity of consent.
* SARS-CoV-2-positive individuals with an asymptomatic or oligosymptomatic infection (mild or oligosymptomatic disease course is defined as absence of fever and respiratory distress or cough not attributable to other known chronic disease).
* OR SARS-CoV-2-negative individuals at the time of inclusion.
* OR post-infectious SARS-CoV-2-negative individuals with acquired immunity to SARS-CoV-2 and a mild disease course.

Exclusion Criteria

* Evolution of the COVID-19 disease requiring a hospital admission before inclusion in the study
* Presence of fever and respiratory distress/cough at the time of inclusion not attributable to other known chronic disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No